• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis.

作者信息

Marchandot Benjamin, Carmona Adrien, Trimaille Antonin, Curtiaud Anais, Morel Olivier

机构信息

Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 Place de l'Hôpital, 67000, Strasbourg, France.

INSERM (French National Institute of Health and Medical Research), FMTS, UMR 1260, Regenerative Nanomedicine, Strasbourg, France.

出版信息

J Thromb Thrombolysis. 2021 Oct;52(3):689-691. doi: 10.1007/s11239-021-02505-4. Epub 2021 Jun 15.

DOI:10.1007/s11239-021-02505-4
PMID:34129181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8204296/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dba/8204296/08d9de915518/11239_2021_2505_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dba/8204296/08d9de915518/11239_2021_2505_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dba/8204296/08d9de915518/11239_2021_2505_Fig1_HTML.jpg

相似文献

1
Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis.促凝微粒：疫苗诱导的免疫性血小板减少症（VITT）与脑静脉窦血栓形成之间的可能联系。
J Thromb Thrombolysis. 2021 Oct;52(3):689-691. doi: 10.1007/s11239-021-02505-4. Epub 2021 Jun 15.
2
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors.疫苗诱导的免疫性血栓性血小板减少症（VITT）：用布鲁顿酪氨酸激酶抑制剂靶向发病机制。
Thromb Haemost. 2021 Nov;121(11):1395-1399. doi: 10.1055/a-1481-3039. Epub 2021 May 28.
3
Potential mechanisms of vaccine-induced thrombosis.疫苗诱导血栓形成的潜在机制。
Eur J Intern Med. 2022 Nov;105:1-7. doi: 10.1016/j.ejim.2022.08.002. Epub 2022 Aug 8.
4
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.腺病毒载体新冠疫苗诱导的免疫性血栓性血小板减少症的相关认识。
Blood. 2021 Dec 2;138(22):2256-2268. doi: 10.1182/blood.2021013231.
5
A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.流式细胞术检测 ChAdOx1 nCov-19 疫苗接种后 VITT 中的血小板激活抗体。
Blood. 2021 Jul 1;137(26):3656-3659. doi: 10.1182/blood.2021012064.
6
[Uncommon thrombotic complications after SARS-CoV-2 vaccination].[新型冠状病毒2型疫苗接种后罕见的血栓形成并发症]
Vnitr Lek. 2021 Winter;67(5):297-302.
7
Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).疫苗诱导的免疫性血栓性血小板减少症（VITT）的发病机制。
Semin Hematol. 2022 Apr;59(2):97-107. doi: 10.1053/j.seminhematol.2022.02.004. Epub 2022 Feb 23.
8
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.抗血小板因子 4 抗体导致的 VITT 与 SARS-CoV-2 刺突蛋白不发生交叉反应。
Blood. 2021 Oct 7;138(14):1269-1277. doi: 10.1182/blood.2021012938.
9
Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia.澳大利亚和新西兰对疫苗诱导的免疫性血栓形成和血小板减少症的诊断与管理方法。
Med J Aust. 2021 Sep 20;215(6):245-249.e1. doi: 10.5694/mja2.51229. Epub 2021 Sep 6.
10
Perspectives on vaccine induced thrombotic thrombocytopenia.疫苗诱导的血栓性血小板减少症的观点。
J Autoimmun. 2021 Jul;121:102663. doi: 10.1016/j.jaut.2021.102663. Epub 2021 May 18.

引用本文的文献

1
How We Interpret Thrombosis with Thrombocytopenia Syndrome?我们如何解读血栓性血小板减少性紫癜？
Int J Mol Sci. 2024 May 1;25(9):4956. doi: 10.3390/ijms25094956.
2
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19.与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗相关的脑静脉窦血栓形成（CVST）：新型冠状病毒肺炎（COVID-19）中观察到的CVST共同免疫发病机制线索
J Anesth Analg Crit Care. 2021 Nov 18;1(1):15. doi: 10.1186/s44158-021-00020-9.
3
Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia.

本文引用的文献

1
Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT).疫苗诱导的免疫性血小板减少症和血栓形成（VITT）
Res Pract Thromb Haemost. 2021 Jun 1;5(5):e12529. doi: 10.1002/rth2.12529. eCollection 2021 Jun.
2
SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.严重急性呼吸综合征冠状病毒2型疫苗诱导的免疫性血栓性血小板减少症
N Engl J Med. 2021 Jun 10;384(23):2254-2256. doi: 10.1056/NEJMe2106315. Epub 2021 Apr 16.
3
Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death.
血小板-中性粒细胞相互作用与 COVID-19 和疫苗诱导的血栓性血小板减少症。
Front Immunol. 2023 May 19;14:1186000. doi: 10.3389/fimmu.2023.1186000. eCollection 2023.
4
Hematological Questions in Personalized Management of COVID-19 Vaccination.新型冠状病毒肺炎疫苗个性化管理中的血液学问题
J Pers Med. 2023 Jan 30;13(2):259. doi: 10.3390/jpm13020259.
5
Vaccine-induced immune thrombotic thrombocytopenia: current evidence, potential mechanisms, clinical implications, and future directions.疫苗诱导的免疫性血栓性血小板减少症：当前证据、潜在机制、临床意义及未来方向。
Eur Heart J Open. 2021 Aug 2;1(2):oeab014. doi: 10.1093/ehjopen/oeab014. eCollection 2021 Sep.
6
Platelet and extracellular vesicles in COVID-19 infection and its vaccines.血小板和细胞外囊泡在 COVID-19 感染及其疫苗中的作用。
Transfus Apher Sci. 2022 Jun;61(3):103459. doi: 10.1016/j.transci.2022.103459. Epub 2022 May 21.
7
Cardiovascular manifestations secondary to COVID-19: A narrative review.COVID-19 相关心血管表现：综述。
Respir Med Res. 2022 May;81:100904. doi: 10.1016/j.resmer.2022.100904. Epub 2022 May 4.
8
Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.新型冠状病毒肺炎及疫苗诱导的免疫性血栓性血小板减少症中的免疫介导血小板激活
Front Immunol. 2022 Feb 22;13:837629. doi: 10.3389/fimmu.2022.837629. eCollection 2022.
9
Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination.病例报告：ChAdOx1 nCov-19疫苗接种后疫苗诱导的血栓性血小板减少症中的颗粒增多血小板
Front Cardiovasc Med. 2022 Feb 9;9:824601. doi: 10.3389/fcvm.2022.824601. eCollection 2022.
10
COVID-19, Vaccines, and Thrombotic Events: A Narrative Review.2019冠状病毒病、疫苗与血栓形成事件：一篇叙述性综述
J Clin Med. 2022 Feb 11;11(4):948. doi: 10.3390/jcm11040948.
含血小板因子4的免疫复合物诱导血小板活化，随后导致钙蛋白酶依赖性血小板死亡。
Cell Death Discov. 2019 Jun 24;5:106. doi: 10.1038/s41420-019-0188-0. eCollection 2019.
4
Autoimmune heparin-induced thrombocytopenia.自身免疫性肝素诱导的血小板减少症。
J Thromb Haemost. 2017 Nov;15(11):2099-2114. doi: 10.1111/jth.13813. Epub 2017 Sep 28.
5
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?活化血小板衍生和白细胞衍生的循环微颗粒与肝素诱导的血小板减少症中的血栓形成风险：PF4 载脂蛋白微颗粒的作用？
Cytometry B Clin Cytom. 2018 Mar;94(2):334-341. doi: 10.1002/cyto.b.21507. Epub 2017 Jan 13.
6
PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.PF4/肝素抗体复合物通过激活 FcγRI 诱导单核细胞组织因子表达和组织因子阳性微粒的释放。
Blood. 2012 May 31;119(22):5285-93. doi: 10.1182/blood-2011-06-359430. Epub 2012 Mar 6.
7
Role of coagulation factors in cerebral venous sinus and cerebral microvascular thrombosis.凝血因子在脑静脉窦和脑微血管血栓形成中的作用。
Neurosurgery. 2010 Mar;66(3):560-5; discussion 565-6. doi: 10.1227/01.NEU.0000365745.49583.FD.
8
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.血液凝固外源性途径在止血和血栓形成中的作用。
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1687-93. doi: 10.1161/ATVBAHA.107.141911. Epub 2007 Jun 7.
9
Newer insights on the mechanism of heparin-induced thrombocytopenia.肝素诱导的血小板减少症机制的新见解。
Semin Thromb Hemost. 2004 Feb;30 Suppl 1:57-67. doi: 10.1055/s-2004-823004.
10
Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells.来自肝素诱导的血小板减少症患者的抗血小板因子4/肝素抗体可直接激活微血管内皮细胞。
Int Immunol. 2002 Feb;14(2):121-9. doi: 10.1093/intimm/14.2.121.